JPMorgan Chase & Co. Increases Stock Position in Invesco Dividend Achievers ETF (NASDAQ:PFM)
JPMorgan Chase & Co. boosted its stake in shares of Invesco Dividend Achievers ETF (NASDAQ:PFM – Free Report) by 12.3% in the 3rd quarter, according to the company in its most recent disclosure with ...
suncoastnews14d
Tempus Projects exhibition to showcase private photographs of John Lennon by May Pang
“The Lost Weekend — The Photography of May Pang” will be presented Friday through Sunday, Jan. 24-26, at Tempus Projects, 1624 E. Seventh Ave., second floor, in Ybor City. Admission to the exhibit is ...
Benzinga.com15d
Tempus AI: A Game-Changer in AI-Powered Healthcare
On Tuesday, Tempus first caught investors’ attention following a routine trading disclosure by former House Speaker Nancy Pelosi. On January 14, Pelosi purchased 50 call options on Tempus stock ...
Seeking Alpha16d
Tempus AI Has A High Probability Of Profitability In 2025
Tempus AI, Inc. is projected to achieve 30% YoY top line growth in Q4 2024 as presented in management's preliminary results. Growth is forecast to continue in the 23-25% range in eFY25. Tempus is ...
Stockhouse16d
Tempus Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of olivia. olivia is an AI-enabled ...
Joplin Globe16d
Tempus Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of olivia. olivia is an AI ...
MarketWatch22d
Tempus AI Shares Rise on Launch of Cancer-Profiling Device
Tempus AI shares were up 14%, to $36.42, after the company launched its FDA-approved in vitro diagnostic device, xT CDx. The healthcare technology company said Wednesday that, beginning today, xT ...
Seeking Alpha22d
Tempus AI: Disappointing Q4 Preliminary Results, But Bullish Fundamental Update
Tempus AI is a leading player in healthcare AI, aiming to deliver personalized treatment suggestions through its proprietary data model. Preliminary Q4 results and 2025 guidance show mixed ...
Business Wire22d
Tempus Announces the National Launch of FDA-Approved xT CDx Test
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of the ...
BioSpace22d
Tempus Announces the National Launch of FDA-Approved xT CDx Test
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of the ...
Insider Monkey23d
Tempus AI (TEM) Launches AI-Powered Whole-Genome Sequencing Test to Transform Precision Medicine
In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against other important AI news and ratings on investors’ radar. On Monday, the US government revealed ...